Overall Technical outlook

Price Summary

On 2026-02-02, Eris Lifesciences Limited's stock began at 1375.0, peaked at 1398.0, bottomed at 1357.1, and closed 0.61% higher at 1383.4, with a volume of 40258 shares.
Over the past year, the stock's highest price was 1847.7, and its lowest was 1180.95.
10 analysts suggest that ERIS's future price will lie between 1530.0 and 1940.0, with an average expected price of roughly 1786.2.

Technicals

Support and Resistance: The current price is 1383.4, with support at 1385.6 and resistance at 1385.6. This range suggests that the price might move between these levels, with 1385.6 offering support and 1385.6 capping further gains for Eris Lifesciences Limited.
ERIS supportResistance 8554cc
Support/Resistance for ERIS


Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
ERIS aroon 8554cc
Aroon chart for Eris Lifesciences Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
ERIS bbands 8554cc
Bolinger Bands chart for Eris Lifesciences Limited


Parabolic SAR: The PSAR remains bearish, reinforcing a resistance level that could restrict any upward movement. This resistance indicates that the market may remain under bearish control, with limited potential for gains.
ERIS psar 8554cc
Parabolic Stop and Reverse chart for Eris Lifesciences Limited


Stochastic: The STOCHASTIC is currently in a neutral position for Eris Lifesciences Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
ERIS stoch 8554cc
Stochastic chart for Eris Lifesciences Limited


Tripple Moving Agerage: A bullish trend is signaled by the alignment of the 20-50-100 period moving averages, but the slopes of the faster averages suggest a potential reversal. The weakening momentum in the shorter-term averages hints that the current upward trend might be nearing its end, signaling the possibility of a shift in direction.
ERIS trippleSMA 8554cc
Tripple SMA chart for Eris Lifesciences Limited


A thorough analysis of a company involves looking beyond its stock price movements and trading patterns. You must also examine its fundamentals, which include profitability, growth prospects, and competitive advantages. Additionally, the industry in which the company operates provides important context, as factors like technological innovations, regulation, and market demand influence performance. By integrating this information with technical analysis, more accurate predictions about the company's future can be made.